Finnish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Nanoform Finland Oyj

Market Cap: €85.2m

Engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States.

Orion Oyj

Market Cap: €9.1b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Herantis Pharma Oyj

Market Cap: €44.3m

A clinical stage biotechnology company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson’s disease (PD).